Advertisement
Home »

Cost-effectiveness of recombinant zoster vaccine for adults aged ≥50 years in China.

May 15, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE EXPERTS

  • Minghuan Jiang

    Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, China, 710061; Institute for Global Health and Development, Peking University, Beijing, China, 100091.

    Xuelin Yao

    Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, China, 710061; Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an, China, 710061; Shaanxi Center for Health Reform and Development Research, Xi’an, China, 710061; Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, Western China Science & Technology Innovation Harbor, Xi’an, China, 712000.

    Jin Peng

    Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, China, 710061; Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an, China, 710061; Shaanxi Center for Health Reform and Development Research, Xi’an, China, 710061; Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, Western China Science & Technology Innovation Harbor, Xi’an, China, 712000.

    Liuxin Feng

    Department of Pharmacy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China, 710004.

    Yue Ma

    Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, China, 710061; Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an, China, 710061; Shaanxi Center for Health Reform and Development Research, Xi’an, China, 710061; Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, Western China Science & Technology Innovation Harbor, Xi’an, China, 712000.

    Xinke Shi

    Health Science Center, Xi’an Jiaotong University, Xi’an, China, 710061.

    Yu Fang

    Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, China, 710061; Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an, China, 710061; Shaanxi Center for Health Reform and Development Research, Xi’an, China, 710061; Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, Western China Science & Technology Innovation Harbor, Xi’an, China, 712000. Electronic address: yufang@xjtu.edu.cn.

    Hai Fang

    China Center for Health Development Studies, Peking University, Beijing, China, 100191; Peking University Health Science Center, Chinese Center for Disease Control and Prevention Joint Research Center for Vaccine Economics, Beijing, China, 100191. Electronic address: hfang@hsc.pku.edu.cn.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement